Argoff C E, Kaneski C R, Blanchette-Mackie E J, Comly M, Dwyer N K, Brown A, Brady R O, Pentchev P G
Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.
Biochem Biophys Res Commun. 1990 Aug 31;171(1):38-45. doi: 10.1016/0006-291x(90)91353-t.
Type C Niemann-Pick disease (NPC) is an autosomal recessive neurovisceral storage disorder in which defective intracellular cholesterol processing has been demonstrated in fibroblasts from NPC patients and obligate heterozygotes. In the present paper, the ability to esterify LDL-cholesterol was examined in cultured lymphocytes from 8 NPC patients, 8 obligate heterozygotes and 8 controls. Cholesteryl ester synthesis was 8% (+/- 5%) and 45% (+/- 16%) of controls in homozygous and heterozygous cell lines, respectively. Histochemical and electron microscopic examinations confirmed that this biochemical lesion was associated with abnormal intracellular accumulation of unesterified cholesterol in mutant lymphocytes. These results demonstrate that measurement of cholesterol esterification in cultured lymphocytes offers a quick and reliable means of confirming the diagnosis of NPC and that these cells may be useful for probing the primary molecular lesion of NPC.
C型尼曼-匹克病(NPC)是一种常染色体隐性神经内脏贮积病,在NPC患者和纯合子携带者的成纤维细胞中已证实存在细胞内胆固醇加工缺陷。在本文中,对8例NPC患者、8例纯合子携带者和8例对照者的培养淋巴细胞酯化低密度脂蛋白胆固醇的能力进行了检测。纯合子和杂合子细胞系中胆固醇酯合成分别为对照的8%(±5%)和45%(±16%)。组织化学和电子显微镜检查证实,这种生化损伤与突变淋巴细胞中未酯化胆固醇的细胞内异常蓄积有关。这些结果表明,检测培养淋巴细胞中的胆固醇酯化作用为确诊NPC提供了一种快速可靠的方法,并且这些细胞可能有助于探究NPC的原发性分子损伤。